Roivant Sciences Ltd to Review Results from ADORING 2 Phase 3 Trial in Atopic Dermatitis Call Transcript - Thomson StreetEvents

Roivant Sciences Ltd to Review Results from ADORING 2 Phase 3 Trial in Atopic Dermatitis Call Transcript

Roivant Sciences Ltd to Review Results from ADORING 2 Phase 3 Trial in Atopic Dermatitis Call Transcript - Thomson StreetEvents
Roivant Sciences Ltd to Review Results from ADORING 2 Phase 3 Trial in Atopic Dermatitis Call Transcript
Published Mar 15, 2023
Published Mar 15, 2023
Price US$ 54.00  |  Buy this Report Now

About This Report

  
Abstract:

Edited Transcript of ROIV.OQ conference call or presentation 15-Mar-23 12:00pm GMT

  
Report Type:

Transcript

Source:
Company:
Roivant Sciences Ltd
Ticker
ROIV.OQ
Time
12:00pm GMT
Format:
PDF Adobe Acrobat
Buy Now

Roivant Sciences Ltd to Review Results From the Chronic Period of TUSCANY-2 Investor Call Transcript – 2023-06-22 – US$ 54.00 – Edited Transcript of ROIV.OQ conference call or presentation 22-Jun-23 12:00pm GMT

Roivant Sciences Ltd at Goldman Sachs Healthcare Conference Transcript – 2023-06-12 – US$ 54.00 – Edited Transcript of ROIV.OQ presentation 12-Jun-23 5:00pm GMT

Roivant Sciences Ltd at Jefferies Healthcare Conference Transcript – 2023-06-07 – US$ 54.00 – Edited Transcript of ROIV.OQ presentation 7-Jun-23 2:00pm GMT

Roivant Sciences Ltd at Bank of America Global Healthcare Conference Transcript – 2023-05-11 – US$ 54.00 – Edited Transcript of ROIV.OQ presentation 11-May-23 5:40pm GMT

Roivant Sciences Ltd at H.C. Wainwright BioConnect Investor Conference Transcript – 2023-05-02 – US$ 54.00 – Edited Transcript of ROIV.OQ presentation 2-May-23 5:00pm GMT

Roivant Sciences Ltd Q3 2022 Earnings Call Transcript – 2023-02-13 – US$ 54.00 – Edited Transcript of ROIV.OQ earnings conference call or presentation 13-Feb-23 1:00pm GMT

Roivant Sciences Ltd at JPMorgan Healthcare Conference Transcript – 2023-01-09 – US$ 54.00 – Edited Transcript of ROIV.OQ presentation 9-Jan-23 10:15pm GMT

Roivant Sciences Ltd at Goldman Sachs CEOs Unscripted Conference Transcript – 2023-01-05 – US$ 54.00 – Edited Transcript of ROIV.OQ presentation 5-Jan-23 7:55pm GMT

Roivant Sciences Ltd to Announce Positive Results From the Induction Period of the TUSCANY-2 Call Transcript – 2023-01-04 – US$ 54.00 – Edited Transcript of ROIV.OQ conference call or presentation 4-Jan-23 1:00pm GMT

Roivant Sciences Ltd Q2 2022 Earnings Call Transcript – 2022-11-14 – US$ 54.00 – Edited Transcript of ROIV.OQ earnings conference call or presentation 14-Nov-22 1:00pm GMT

More from Thomson StreetEvents

Thomson StreetEvents—Thomson StreetEvents is a leading provider of Web-based solutions for the investment community, offering services that transform the way companies communicate and meet disclosure requirements while assisting investors in managing and leveraging this information. Thomson StreetEvents service offers institutional investors a one-stop solution for managing corporate disclosure information by aggregating conference calls, webcasts, transcripts, call summaries, and other financial information into a time-saving, efficiency tool.
Purchase Thomson StreetEvents' Transcripts (verbatim reports) and Briefs (call summaries) of earnings, guidance, M&A and other corporate calls directly through Alacra. Discounted prices apply to reports produced over two weeks ago.

About the Author


Cite this Report

  
MLA:
Thomson StreetEvents. "Roivant Sciences Ltd to Review Results from ADORING 2 Phase 3 Trial in Atopic Dermatitis Call Transcript" Mar 15, 2023. Alacra Store. Nov 06, 2026. <http://www.alacrastore.com/thomson-streetevents-transcripts/Roivant-Sciences-Ltd-to-Review-Results-from-ADORING-2-Phase-3-Trial-in-Atopic-Dermatitis-Call-T15515226>
  
APA:
Thomson StreetEvents. (2023). Roivant Sciences Ltd to Review Results from ADORING 2 Phase 3 Trial in Atopic Dermatitis Call Transcript Mar 15, 2023. New York, NY: Alacra Store. Retrieved Nov 06, 2026 from <http://www.alacrastore.com/thomson-streetevents-transcripts/Roivant-Sciences-Ltd-to-Review-Results-from-ADORING-2-Phase-3-Trial-in-Atopic-Dermatitis-Call-T15515226>
  
US$ 54.00
$  £  €
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our Credit Research from one place.